Emergency Use Authorization for COVID-19 antibody

Coronavirus Vaccines

The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.

The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

This includes those who are 65 years of age or older or who have certain chronic medical conditions.

The treatment is part of a class of drugs known as monoclonal antibodies, which are manufactured copies of antibodies created by the human body to fight infections.

Read the full article here.

Like this article?

Facebook
Twitter
LinkedIn
Pinterest

More Articles

Go Red for Women

Go Red For Women!

To support the American Heart Association and Wear Red Day, Premier Specialty Network is reminding you to wear red tomorrow, Friday, February 1 2019!

Bed Bugs

How To Get Rid Of Bed Bugs

Bed bugs are seen as a growing problem within all types of dwellings, including private homes, dormitories, cruise ships, army barracks, and shelters.